retatrutide clinical trial sites for weight loss: Study shows 30% body weight loss Lilly's triple agonist achieves 16.8%

Funding: The present study was partly supported by the Samuel Rahbar Diabetes and Drug Discovery Endowment, Arthur Riggs Diabetes & Metabolism Research Institute and innovation grant from the Wanek Family Project for Type 1 Diabetes at City of Hope

However, there is little scientific evidence to support this claim

Inflammopharmacology 7:114 Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V, Aralica G, Konjevoda P, Batelja L, Blagaic AB (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse

The job of glutathione is to break down hydrogen peroxide